Pharmacology, Toxicology and Pharmaceutical Science
Omega-3 Fatty Acid
100%
Placebo
39%
End Stage Renal Disease
28%
Fatty Acid
28%
Chronic Kidney Failure
26%
Heart Infarction
24%
Hemodialysis
24%
C Reactive Protein
20%
Sudden Cardiac Death
19%
Cardiovascular Disease
19%
Polyunsaturated Fatty Acid
18%
Psoriatic Arthritis
15%
Coronary Artery Disease
12%
Phospholipid
12%
Kidney Disease
12%
Docosahexaenoic Acid
11%
Ischemic Heart Disease
11%
Heart Ventricle Arrhythmia
11%
Normal Human
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Lipoprotein
9%
Linolenic Acid
9%
Cell Adhesion Molecule
7%
Atorvastatin
7%
Haptoglobin
7%
Antiarrhythmic Agent
6%
Low Density Lipoprotein Cholesterol
6%
Atrial Fibrillation
5%
Intervention Trial
5%
Inflammation
5%
Diabetes Mellitus
5%
Heart Arrhythmia
5%
Immunology and Microbiology
Heart Rate Variability
19%
Hemodialysis
12%
Adipose Tissue
9%
Blood Plasma
9%
Coronary Artery
9%
Blood Level
8%
Adiponectin
7%
Normal Human
7%
Psoriatic Arthritis
7%
C-Reactive Protein
7%
Phospholipid Blood Level
6%
Platelet
6%
RR Interval
5%
Medicine and Dentistry
Nephropathy
11%
Heart Rate Variability
10%
Chronic Kidney Disease
6%
Sudden Cardiac Death
5%
Ischemic Heart Disease
5%
